ArticleScientific reports2020

Novel candidate drugs in anti-tumor necrosis factor refractory Crohn's diseases: in silico study for drug repositioning.

Min Seob Kwak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.